These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 23981754)
1. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study. Hassan AA; Habib HM; Eissa AA Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754 [TBL] [Abstract][Full Text] [Related]
2. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study. Hassan AA; Habib HM; Eissa AA Int J Rheum Dis; 2013 Jan; ():. PubMed ID: 26119882 [TBL] [Abstract][Full Text] [Related]
3. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. Abdel-Wahab AF; Fathy O; Al-Harizy R Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [TBL] [Abstract][Full Text] [Related]
5. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus]. Fischer K Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227 [TBL] [Abstract][Full Text] [Related]
6. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Pratt JE; Tracy RP; Kuller LH; Manzi S Arthritis Rheum; 2004 Jan; 50(1):151-9. PubMed ID: 14730611 [TBL] [Abstract][Full Text] [Related]
7. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. Park YJ; Shin YJ; Kim WU; Cho CS Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Manzi S; Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Rairie JE; Tracy RP; Kuller LH Arthritis Rheum; 1999 Jan; 42(1):51-60. PubMed ID: 9920014 [TBL] [Abstract][Full Text] [Related]
9. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Rizk A; Gheita TA; Nassef S; Abdallah A Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605 [TBL] [Abstract][Full Text] [Related]
10. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Shang Q; Tam LS; Li EK; Yip GW; Yu CM Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277 [TBL] [Abstract][Full Text] [Related]
11. Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients. Parra S; Cabré A; Marimon F; Ferré R; Ribalta J; Gonzàlez M; Heras M; Castro A; Masana L Lupus; 2014 Mar; 23(3):245-54. PubMed ID: 24390652 [TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. Ajeganova S; Gustafsson T; Jogestrand T; Frostegård J; Hafström I Arthritis Res Ther; 2015 Mar; 17(1):84. PubMed ID: 25885788 [TBL] [Abstract][Full Text] [Related]
13. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up. Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141 [TBL] [Abstract][Full Text] [Related]
14. Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors. Erdozain JG; Villar I; Nieto J; Ruiz-Irastorza G J Rheumatol; 2014 Feb; 41(2):310-7. PubMed ID: 24429176 [TBL] [Abstract][Full Text] [Related]
15. Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. Elwy MA; Galal ZA; Hasan HE East Mediterr Health J; 2010 Aug; 16(8):893-900. PubMed ID: 21469572 [TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia in males with systemic lupus erythematosus. Mok CC; Lau CS; Lee KW; Wong RW J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430 [TBL] [Abstract][Full Text] [Related]
17. [Clinico-biological issues of systemic lupus erythematosus patients]. Belibou IC; Ancuţa C; Miu S; Ancuţa E; Păstrăguş C; Chirieac R Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):83-9. PubMed ID: 23077877 [TBL] [Abstract][Full Text] [Related]
18. Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus. Kay SD; Poulsen MK; Diederichsen AC; Voss A J Rheumatol; 2016 Feb; 43(2):315-22. PubMed ID: 26628595 [TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
20. Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus. Radwan MM; El-Lebedy D; Fouda R; Elsorougy E Clin Rheumatol; 2014 Apr; 33(4):493-8. PubMed ID: 24077952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]